All News about Penumbra Inc
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/november/mmc/midday-market-stats-november-132023.png?sfvrsn=a873a806_2)
![](https://cdn.benzinga.com/files/images/story/2023/11/13/monday.com_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
What 5 Analyst Ratings Have To Say About Penumbra
November 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
November 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
Penumbra Inc. (NYSE: PEN) Highlighted for Surprising Price Action
September 06, 2023
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Penumbra's Future
September 06, 2023
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Buy These 3 Low-Beta Stocks To Counter Market Volatility
September 11, 2023
Via Talk Markets
Topics
Economy
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Analyst Ratings for Penumbra
August 02, 2023
Via Benzinga
Penumbra Inc. (NYSE: PEN) is a Stock Spotlight on 7/5
July 05, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/04/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/02/pen.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/02/exact_sciences_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
10 Analysts Have This to Say About Penumbra
May 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/19/pen.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Penumbra Stands With Analysts
March 29, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://investorplace.com/wp-content/uploads/2020/06/death-stocks-to-sell.jpg)
![](https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.marketbeat.com/logos/articles/small_20230309151633_are-these-medical-device-makers-getting-ready-to-r.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.